1Fagiolo U, Cossarizza A, Scala E, et al: Increased eytokine production in mononuclear eells of heallh) elderly people.Eur J Intmunol.1993, 23:2375 - 2378.
2Whisler RL, Chen M, Beiqing L, et al. Impaired induction of cfos/c-jun genes and of Iranscriptional regulatory proleins binding distinct c-fose/c-jun promoter elements in activated human T cells during aging. Cell Immunol, 1997, 175:41 -50.
3Kammer GM, Mishra N. Syslemic lupus erythemalosus in lhe elderly,Rheum Dis Clin Noah Am, 2000, 26: 475- 492.
4Nived O, Jonsen A, Bengtsson AA, et al. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol, 2002, 29:1398 - 1400.
5Maddison PJ. Systemic lupus erythematosus in the elderly. J Rheumatol 1987, 14:182 - 187.
6Mak SK, Lain EKM, Wong AKM. Clinical profile of patients with late - onset SLE: not a benign subgroup. Lupus, 1998.7:28 - 28.
7Costallat LT, Colmbra AM: Systemic lupus erythemalosus: Clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol, 1994, 12:603 - 607.
8Font J, Pallares L, Cervera R, et al: Systemic lupus erythematosus in the elderly: Clinical and immunological characteristics. Ann Rheum Dis,1991,50:702 - 705.
9Dennis MS, Byrne EJ, Hopkinson N, et al. Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. J Neurol Neurosurg Psychiatry. 1992,55:1157 - 1161.
10Pu SJ, Luo SF, Wu YLL, et al. The clinical fealures and prognosis of lupus with disease onset at age 65 and older, lupus, 2000, 9:96 -100.
